Xian‐Geng Hou
About
Xian‐Geng Hou is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Surgery.
According to data from OpenAlex, Xian‐Geng Hou has authored 32 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 13 papers in Oncology and 10 papers in Surgery. Recurrent topics in Xian‐Geng Hou's work include Inflammatory Biomarkers in Disease Prognosis (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Acute Myocardial Infarction Research (9 papers). Xian‐Geng Hou is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Acute Myocardial Infarction Research (9 papers). Xian‐Geng Hou collaborates with scholars based in China and United States. Xian‐Geng Hou's co-authors include Yi Yang, Ying‐Ying Zheng, Tingting Wu, Yi‐Tong Ma, Xiang Xie, You Chen, Xiang Xie, Haitao Yang, Jinying Zhang and Xiang Ma and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Thrombosis and Haemostasis and BMJ Open.
In The Last Decade
Xian‐Geng Hou
31 papers receiving 334 citations
Peers
Xian‐Geng Hou
Zhijun Sun China
Gustavo Neves de Araújo Brazil
Janusz Szkodziński Poland
Ivana Ćelap Croatia
Jianqing She China
Ertuğrul Okuyan Türkiye
Boris Starčević Croatia
Kensuke Matsushita France
Faysal Şaylık Türkiye
Jonas Rusnak Germany
Citations per year, relative to Xian‐Geng Hou Xian‐Geng Hou (= 1×)
peers
Zhijun Sun
Countries citing papers authored by Xian‐Geng Hou
Since
Specialization
Citations
This map shows the geographic impact of Xian‐Geng Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian‐Geng Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian‐Geng Hou more than expected).
Fields of papers citing papers by Xian‐Geng Hou
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Xian‐Geng Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian‐Geng Hou. The network helps show where Xian‐Geng Hou may publish in the future.
Co-authorship network of co-authors of Xian‐Geng Hou
This figure shows the co-authorship network connecting the top 25 collaborators of Xian‐Geng Hou. A scholar is included among the top collaborators of Xian‐Geng Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xian‐Geng Hou. Xian‐Geng Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wen, Zhi‐Ying, Ting‐Ting Wu, Xian‐Geng Hou, et al.. (2024). Association of hemoglobin glycation index with clinical outcomes in patients with coronary artery disease: a prospective cohort study. Diabetology & Metabolic Syndrome. 16(1). 241–241.
2.
Wu, Tingting, Ying Pan, Shun Wang, et al.. (2024). Association between extremely high prognostic nutritional index and all-cause mortality in patients with coronary artery disease: secondary analysis of a prospective cohort study in China. BMJ Open. 14(6). e079954–e079954.
3.
Hou, Xian‐Geng, et al.. (2024). Serum 5′-Nucleotidase as a Novel Predictor of Adverse Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Coronary Artery Disease. Reviews in Cardiovascular Medicine. 25(1). 17–17.
4.
Pan, Ying, Tingting Wu, Yi Yang, et al.. (2024). Association between the C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index and Adverse Clinical Outcomes in CAD Patients after PCI: Findings of a Real-World Study. Reviews in Cardiovascular Medicine. 25(4). 111–111.
5.
Zheng, Ying‐Ying, Tingting Wu, Xian‐Geng Hou, et al.. (2023). Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study. Thrombosis and Haemostasis. 125(2). 178–187.
6.
Zheng, Ying‐Ying, Tingting Wu, Xian‐Geng Hou, et al.. (2023). Serum a-1 Antitrypsin as a Novel Biomarker in Chronic Heart Failure. ESC Heart Failure. 10(5). 2865–2874.
7.
Wu, Ting‐Ting, Ying‐Ying Zheng, Xiang Ma, et al.. (2023). Mutated CYP17A1 promotes atherosclerosis and early-onset coronary artery disease. Cell Communication and Signaling. 21(1). 155–155.
8.
Hou, Xian‐Geng, Tingting Wu, Ying‐Ying Zheng, et al.. (2023). The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort. Journal of Cardiovascular Translational Research. 16(5). 1177–1183.
9.
Wu, Ting‐Ting, Ying Pan, Ying‐Ying Zheng, et al.. (2023). Age–Bilirubin–International Normalized Ratio (INR)–Creatinine (ABIC) Score, a Potential Prognostic Model for Long-Term Mortality of CAD Patients After PCI. Journal of Inflammation Research. Volume 16. 333–341.
10.
Pan, Ying, Tingting Wu, Xian‐Geng Hou, et al.. (2023). Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial. Platelets. 34(1). 2206915–2206915.
11.
Wang, Sifan, Tingting Wu, Ying‐Ying Zheng, et al.. (2023). Serum Globulin to Albumin Ratio as a Novel Predictor of Adverse Clinical Outcomes in Coronary Artery Disease Patients Who Underwent PCI. Reviews in Cardiovascular Medicine. 24(10). 278–278.
12.
Ju, Yan, et al.. (2023). Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials. BMJ Open. 13(11). e070827–e070827.
13.
Yang, Haitao, Ying‐Ying Zheng, Ting‐Ting Wu, et al.. (2022). ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention. Frontiers in Cardiovascular Medicine. 9. 709868–709868.
14.
Zheng, Ying‐Ying, Ting‐Ting Wu, Xian‐Geng Hou, et al.. (2022). Hemoglobin-to-Red-Cell Distribution Width Ratio Is a Novel Predictor of Long-Term Patient Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study. Frontiers in Cardiovascular Medicine. 9. 726025–726025.
15.
Pan, Ying, Jian Zhang, Tingting Wu, et al.. (2020). Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study. Lipids in Health and Disease. 19(1). 43–43.
16.
Yang, Haitao, et al.. (2020). Cardiac Shock Wave Therapy for Coronary Heart Disease: an Updated Meta-analysis. Brazilian Journal of Cardiovascular Surgery. 35(5). 741–756.
17.
Zheng, Ying‐Ying, Tingting Wu, You Chen, et al.. (2019). Moderate Serum γ-Glutamyl Transferase Level Is Beneficial for Heart Failure After Percutaneous Coronary Intervention. Metabolic Syndrome and Related Disorders. 17(5). 266–271.
18.
Wu, Tingting, Ying‐Ying Zheng, Xian‐Geng Hou, et al.. (2019). Red blood cell distribution width as long-term prognostic markers in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids in Health and Disease. 18(1). 140–140.
19.
Zheng, Ying‐Ying, Tingting Wu, You Chen, et al.. (2019). Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study. Thrombosis and Haemostasis. 119(6). 1021–1030.
20.
Zheng, Ying‐Ying, Tingting Wu, Yi Yang, et al.. (2019). Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial. European Heart Journal - Cardiovascular Pharmacotherapy. 6(4). 211–221.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Zhijun Sun Breakdown of academic impact, for papers by Gustavo Neves de Araújo Breakdown of academic impact, for papers by Janusz Szkodziński Breakdown of academic impact, for papers by Ivana Ćelap Breakdown of academic impact, for papers by Jianqing She Breakdown of academic impact, for papers by Ertuğrul Okuyan Breakdown of academic impact, for papers by Boris Starčević Breakdown of academic impact, for papers by Kensuke Matsushita Breakdown of academic impact, for papers by Faysal Şaylık Breakdown of academic impact, for papers by Jonas Rusnak